www.interpharma.co.th Inter Pharma Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th a surge in revenues from sales of
million compare with performance for the prior year appear as comprehensive operating net Profit of the Company THB 122.62 million, decrease in Profit from the prior year THB 118.61 million, due to the
YoY. Transfer ownership of condominium unit of the ESSE at Singha Complex, the ESSE Asoke and Banyan Tree Residences Riverside Bangkok mainly attributed to the surge. Residential projects for sales as
& expenses (net of tax) from the comparing quarters, the normalized net profit would be approximately THB 72.8 million in 2Q19 comparing to THB 52.4 million in 2Q18 or a surge of 39% . Statement of Financial
: 1. Sales Revenue 1.1 Sales revenue for the 3-months period ended 31 October 2019 For the 3-months period ended 31 October 2019, INGRS registered sales revenue of Baht 695.34 million, a decrease by
oil (CPO) inventory plunged to the level of 170,000 tons compared to the level of 400,000 tons at the same period of previous year, resulted in a surge in crude palm oil price. In addition, the Energy
performance of the Group Unit: Million Baht 2019 2018 Increase (decrease) Variance (%) Total revenues 6,797 8,080 (1,283) (16%) Net profit 331 526 (195) (37%) The Group’s total revenues for 2019 amounted Baht
decrease of 87.66 million Baht from the same quarter last year which was equal to 165.55 million Baht, representing a decrease of 52.95 percent, of which the total decrease in revenue mainly came from sales
Baht, a decrease of 87.66 million Baht from the same quarter last year which was equal to 165.55 million Baht, representing a decrease of 52.95 percent, of which the total decrease in revenue mainly came
) million baht which decrease 19.65 million baht or (208%) by compared with the net profit at 9.46 million baht same period at last year. The changing over than 20% from the main causes as follows: 1. Revenue